• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

17D 黄热病疫苗接种后严重、不良嗜神经和嗜内脏疾病的临床与免疫学见解

Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination.

作者信息

Silva Maria Luiza, Espírito-Santo Luçandra Ramos, Martins Marina Angela, Silveira-Lemos Denise, Peruhype-Magalhães Vanessa, Caminha Ricardo Carvalho, de Andrade Maranhão-Filho Péricles, Auxiliadora-Martins Maria, de Menezes Martins Reinaldo, Galler Ricardo, da Silva Freire Marcos, Marcovistz Rugimar, Homma Akira, Teuwen Dirk E, Elói-Santos Silvana Maria, Andrade Mariléia Chaves, Teixeira-Carvalho Andréa, Martins-Filho Olindo Assis

机构信息

Laboratório de Biomarcadores de Diagnóstico e Monitoração, Centro de Pesquisas René Rachou, FIOCRUZ/Minas, Avenida Augusto de Lima 1715, Barro Preto, Belo Horizonte, Minas Gerais 30190-002, Brazil.

出版信息

Clin Vaccine Immunol. 2010 Jan;17(1):118-26. doi: 10.1128/CVI.00369-09. Epub 2009 Nov 11.

DOI:10.1128/CVI.00369-09
PMID:19906894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2812091/
Abstract

Yellow fever (YF) vaccines (17D-204 and 17DD) are well tolerated and cause very low rates of severe adverse events (YEL-SAE), such as serious allergic reactions, neurotropic adverse diseases (YEL-AND), and viscerotropic diseases (YEL-AVD). Viral and host factors have been postulated to explain the basis of YEL-SAE. However, the mechanisms underlying the occurrence of YEL-SAE remain unknown. The present report provides a detailed immunological analysis of a 23-year-old female patient. The patient developed a suspected case of severe YEL-AVD with encephalitis, as well as with pancreatitis and myositis, following receipt of a 17D-204 YF vaccination. The patient exhibited a decreased level of expression of Fc-gammaR in monocytes (CD16, CD32, and CD64), along with increased levels of NK T cells (an increased CD3(+) CD16(+/-) CD56(+/-)/CD3(+) ratio), activated T cells (CD4(+) and CD8(+) cells), and B lymphocytes. Enhanced levels of plasmatic cytokines (interleukin-6 [IL-6], IL-17, IL-4, IL-5, and IL-10) as well as an exacerbated ex vivo intracytoplasmic cytokine pattern, mainly observed within NK cells (gamma interferon positive [IFN-gamma(+)], tumor necrosis factor alpha positive [TNF-alpha(+)], and IL-4 positive [IL-4(+)]), CD8(+) T cells (IL-4(+) and IL-5(+)), and B lymphocytes (TNF-alpha(+), IL-4(+), and IL-10(+)). The analysis of CD4(+) T cells revealed a complex profile that consisted of an increased frequency of IL-12(+) and IFN-gamma(+) cells and a decreased percentage of TNF-alpha(+), IL-4(+), and IL-5(+) cells. Depressed cytokine synthesis was observed in monocytes (TNF-alpha(+)) following the provision of antigenic stimuli in vitro. These results support the hypothesis that a strong adaptive response and abnormalities in the innate immune system may be involved in the establishment of YEL-AND and YEL-AVD.

摘要

黄热病(YF)疫苗(17D - 204和17DD)耐受性良好,严重不良事件(YEL - SAE)发生率极低,如严重过敏反应、嗜神经不良疾病(YEL - AND)和嗜内脏疾病(YEL - AVD)。病毒和宿主因素被认为可解释YEL - SAE的发生基础。然而,YEL - SAE发生的潜在机制仍不清楚。本报告对一名23岁女性患者进行了详细的免疫学分析。该患者在接种17D - 204黄热病疫苗后出现疑似严重YEL - AVD病例,伴有脑炎,以及胰腺炎和肌炎。患者单核细胞(CD16、CD32和CD64)中Fc - γR表达水平降低,同时自然杀伤T细胞水平升高(CD3(+) CD16(+/-) CD56(+/-)/CD3(+)比值增加)、活化T细胞(CD4(+)和CD8(+)细胞)以及B淋巴细胞水平升高。血浆细胞因子(白细胞介素 - 6 [IL - 6]、IL - 17、IL - 4、IL - 5和IL - 10)水平升高,以及体外胞浆内细胞因子模式加剧,主要见于自然杀伤细胞(γ干扰素阳性[IFN - γ(+)]、肿瘤坏死因子α阳性[TNF - α(+)]和IL - 4阳性[IL - 4(+)])、CD8(+) T细胞(IL - 4(+)和IL - 5(+))以及B淋巴细胞(TNF - α(+)、IL - 4(+)和IL - 10(+))。对CD4(+) T细胞的分析显示出复杂的特征,包括IL - 12(+)和IFN - γ(+)细胞频率增加,以及TNF - α(+)、IL - 4(+)和IL - 5(+)细胞百分比降低。在体外提供抗原刺激后,单核细胞(TNF - α(+))中观察到细胞因子合成受抑。这些结果支持以下假设:强烈的适应性反应和先天性免疫系统异常可能与YEL - AND和YEL - AVD的发生有关。

相似文献

1
Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination.17D 黄热病疫苗接种后严重、不良嗜神经和嗜内脏疾病的临床与免疫学见解
Clin Vaccine Immunol. 2010 Jan;17(1):118-26. doi: 10.1128/CVI.00369-09. Epub 2009 Nov 11.
2
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe.欧洲17D株衍生黄热病疫苗接种不良事件期间的免疫反应。
J Infect Dis. 2008 Jun 1;197(11):1577-84. doi: 10.1086/587844.
3
Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.2007 年至 2010 年期间,8 个非洲国家黄热病预防接种运动后的不良事件。
Vaccine. 2013 Apr 3;31(14):1819-29. doi: 10.1016/j.vaccine.2013.01.054. Epub 2013 Feb 7.
4
Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults.成年人群体接种原发性 17DD 黄热病疫苗后固有和适应性免疫应答中主要细胞因子来源的特征。
Vaccine. 2011 Jan 10;29(3):583-92. doi: 10.1016/j.vaccine.2010.08.046. Epub 2010 Aug 21.
5
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review.老年人中黄热病疫苗相关内脏疾病的风险:系统评价。
Vaccine. 2013 Dec 2;31(49):5798-805. doi: 10.1016/j.vaccine.2013.09.030. Epub 2013 Sep 27.
6
Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases.美国的黄热病疫苗使用情况与神经病变和内脏病变风险:使用三个医疗保健数据库的回顾性队列研究。
Vaccine. 2022 Jan 31;40(5):742-751. doi: 10.1016/j.vaccine.2021.12.047. Epub 2022 Jan 5.
7
Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002.2001 - 2002年美国与17D株黄热病疫苗相关的不良事件
MMWR Morb Mortal Wkly Rep. 2002 Nov 8;51(44):989-93.
8
Yellow fever vaccine-associated neurologic and viscerotropic disease: a 10-year case series of the French National Reference Center for Arboviruses with clinical and immunological insights.黄热病疫苗相关的神经和内脏疾病:法国国家虫媒病毒参考中心 10 年的病例系列,具有临床和免疫学见解。
J Travel Med. 2024 Mar 1;31(2). doi: 10.1093/jtm/taad160.
9
Review of the risks and benefits of yellow fever vaccination including some new analyses.黄热病疫苗接种的风险和益处综述,包括一些新的分析。
Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6.
10
17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.17DD 和 17D-213/77 黄热病减毒株在初次接种儿童中引发平衡的细胞因子谱。
PLoS One. 2012;7(12):e49828. doi: 10.1371/journal.pone.0049828. Epub 2012 Dec 10.

引用本文的文献

1
Fatal viscerotropic and neurotropic disease after yellow fever vaccine: a rare manifestation leading to diagnosis of severe combined immunodeficiency in an infant.黄热病疫苗接种后致命的内脏嗜性和神经嗜性疾病:导致婴儿严重联合免疫缺陷诊断的罕见表现。
Rev Inst Med Trop Sao Paulo. 2024 Aug 26;66:e50. doi: 10.1590/S1678-9946202466050. eCollection 2024.
2
Yellow Fever Vaccine-Related Neurotropic Disease in Brazil Following Immunization with 17DD.巴西17DD免疫接种后发生的黄热病疫苗相关嗜神经病毒疾病
Vaccines (Basel). 2023 Feb 15;11(2):445. doi: 10.3390/vaccines11020445.
3
Yellow Fever Vaccine-Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil.巴西圣保罗州黄热病疫苗相关内脏疾病在兄弟姐妹间的传播
Emerg Infect Dis. 2023 Mar;29(3):493-500. doi: 10.3201/eid2903.220989.
4
Case Report: Yellow Fever Vaccine-Associated Neurotropic Disease and Associated MRI, EEG, and CSF Findings.病例报告:黄热病疫苗相关神经otropic疾病及相关的MRI、EEG和脑脊液检查结果。 (注:这里“neurotropic”常见释义为“亲神经的”,但结合语境可能是个特定专业术语表述不太准确,可根据实际专业情况调整。)
Front Neurol. 2022 Feb 18;12:779014. doi: 10.3389/fneur.2021.779014. eCollection 2021.
5
Comprehensive Overview of Vaccination during Pregnancy in Europe.欧洲孕期疫苗接种综合概述
J Pers Med. 2021 Nov 13;11(11):1196. doi: 10.3390/jpm11111196.
6
Bedside echocardiography to predict mortality of COVID-19 patients beyond clinical data: Data from the PROVAR-COVID study.床旁超声心动图预测 COVID-19 患者临床数据以外的死亡率:来自 PROVAR-COVID 研究的数据。
Rev Soc Bras Med Trop. 2021 Sep 6;54:e03822021. doi: 10.1590/0037-8682-0382-2021. eCollection 2021.
7
The COVID-19 Vaccine Landscape.新型冠状病毒肺炎疫苗全景
Adv Exp Med Biol. 2021;1318:549-573. doi: 10.1007/978-3-030-63761-3_31.
8
Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.下一代减毒活黄热病疫苗候选物:在小动物模型中的安全性和免疫效力。
Vaccine. 2021 Mar 26;39(13):1846-1856. doi: 10.1016/j.vaccine.2021.02.033. Epub 2021 Mar 6.
9
Safety of Administering Live Vaccines During Pregnancy: A Systematic Review and Meta-Analysis of Pregnancy Outcomes.孕期接种活疫苗的安全性:对妊娠结局的系统评价和荟萃分析
Vaccines (Basel). 2020 Mar 11;8(1):124. doi: 10.3390/vaccines8010124.
10
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.在 otherwise healthy 的患者中,若出现对麻疹和风疹减毒活疫苗的不良反应,可能存在 IFNAR1 遗传缺陷。
J Exp Med. 2019 Sep 2;216(9):2057-2070. doi: 10.1084/jem.20182295. Epub 2019 Jul 3.

本文引用的文献

1
Adverse event reports following yellow fever vaccination.黄热病疫苗接种后的不良事件报告。
Vaccine. 2008 Nov 11;26(48):6077-82. doi: 10.1016/j.vaccine.2008.09.009. Epub 2008 Sep 20.
2
Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes.黄热病疫苗相关内脏型疾病病例,伴有病毒血症持续时间延长、强大的适应性免疫反应以及CCR5和RANTES基因多态性
J Infect Dis. 2008 Aug 15;198(4):500-7. doi: 10.1086/590187.
3
Yellow fever-associated viscerotropic disease in Barcelona, Spain.西班牙巴塞罗那的黄热病相关内脏型疾病
J Travel Med. 2008 May-Jun;15(3):202-5. doi: 10.1111/j.1708-8305.2008.00209.x.
4
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe.欧洲17D株衍生黄热病疫苗接种不良事件期间的免疫反应。
J Infect Dis. 2008 Jun 1;197(11):1577-84. doi: 10.1086/587844.
5
Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination.
Vaccine. 2008 Feb 26;26(9):1173-84. doi: 10.1016/j.vaccine.2007.12.035. Epub 2008 Jan 14.
6
Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease.黄热病疫苗相关内脏型疾病导致的致命性多器官衰竭。
Vaccine. 2007 Dec 5;25(50):8480-5. doi: 10.1016/j.vaccine.2007.08.061. Epub 2007 Sep 18.
7
Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?17DD 黄热病初次接种疫苗后,适应性免疫的激活/调节同时出现:这是预防免疫后严重不良反应的关键吗?
Clin Exp Immunol. 2007 Apr;148(1):90-100. doi: 10.1111/j.1365-2249.2006.03317.x.
8
Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.与17D - 204黄热病疫苗接种相关的神经系统疾病:15例报告
Vaccine. 2007 Feb 26;25(10):1727-34. doi: 10.1016/j.vaccine.2006.11.027. Epub 2006 Nov 27.
9
Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection.以干扰素-γ和白细胞介素-10同时升高以及肿瘤坏死因子-α(+)单核细胞频率较低为特征的混合性炎性/调节性细胞因子谱,是恰加斯利什曼原虫感染所致活动性人类内脏利什曼病的标志。
Clin Exp Immunol. 2006 Oct;146(1):124-32. doi: 10.1111/j.1365-2249.2006.03171.x.
10
Yellow fever vaccine-associated viscerotropic disease and death in Spain.西班牙的黄热病疫苗相关嗜内脏性疾病及死亡
J Clin Virol. 2006 Jun;36(2):156-8. doi: 10.1016/j.jcv.2006.02.005. Epub 2006 Apr 4.